Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06116851 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prostate Metabolism, Cancer Risk and Gut Microbiota

Study acronym: PROMIC
StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 3, 2023 (before its estimated January 15, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Recruiting
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, single center translational multiple cohort study to investigate the association of gut microbiota and prostate cancer.
Trial Details
NCT Number NCT06116851
Lead Sponsor Turku University Hospital
Collaborators: University of Turku
Conditions
(from sponsor)		 Prostate Cancer, Prostate Hyperplasia
Related terms Prostatic Hyperplasia, Prostatic Neoplasms
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov